학술논문
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
Document Type
Article
Author
Source
In: Pharmaceuticals . (Pharmaceuticals, April 2024, 17(4))
Subject
Language
English
ISSN
14248247